INVO Bioscience, Inc. (36)
Browse by Contract Category
Contracts
-
Partnership Agreement
(Filed With SEC on April 13, 2021)
-
Lease, dated March 2021, with Trustmark National Bank
(Filed With SEC on March 30, 2021)
-
Description of Capital Stock
(Filed With SEC on March 30, 2021)
-
HRCFG INVO LLC limited liability company agreement
(Filed With SEC on March 15, 2021)
-
Amendment No. 1 to Distribution Agreement
(Filed With SEC on March 8, 2021)
-
Joint Venture Agreement (Malaysia)
(Filed With SEC on November 25, 2020)
-
Employment Agreement, dated January 15, 2020
(Filed With SEC on January 21, 2020)
-
Press Release dated March 15, 2021
(Filed With SEC on March 15, 2021)
-
Distribution Agreement
(Filed With SEC on December 8, 2020)
-
Distribution Agreement
(Filed With SEC on November 25, 2020)
-
Joint Venture Agreement (Macedonia)
(Filed With SEC on November 25, 2020)
-
Underwriting Agreement, dated November 12, 2020, by and between the Company and Roth Capital Partners, LLC
(Filed With SEC on November 13, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on November 9, 2020)
-
Pre-Incorporation and Shareholders Agreement
(Filed With SEC on September 30, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on September 21, 2020)
-
Form of Secured Convertible Note
(Filed With SEC on June 26, 2020)
-
Form of Unit Purchase Option
(Filed With SEC on June 26, 2020)
-
Securities Purchase Agreement
(Filed With SEC on June 26, 2020)
-
Placement Agent Agreement
(Filed With SEC on June 26, 2020)
-
Form of Registration Rights Agreement
(Filed With SEC on May 15, 2020)
-
Form of Warrant
(Filed With SEC on May 15, 2020)
-
Form of Security Agreement
(Filed With SEC on May 15, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on May 15, 2020)
-
Form of Unit Purchase Option
(Filed With SEC on May 15, 2020)
-
Form of Secured Convertible Note
(Filed With SEC on May 15, 2020)
-
Commercial Lease Agreement dated May 1, 2019 between the registrant and PJ LLC
(Filed With SEC on March 30, 2020)
-
Joint Venture Agreement, dated January 13, 2020, between INVO Bioscience, Inc. and Medesole Healthcare and Trading Private Limited, India
(Filed With SEC on January 16, 2020)
-
Settlement Agreement and General Release dated November 11, 2019
(Filed With SEC on November 14, 2019)
-
Agreement for Release of Claims and Stock Option dated October 29, 2019 with James Bowdring
(Filed With SEC on November 14, 2019)
-
Agreement for Release of Claims and Stock Option dated October 29, 2019 with Kathleen Karloff
(Filed With SEC on November 14, 2019)
-
Employment Offer Letter with Steve Shum
(Filed With SEC on October 15, 2019)
-
CONVERTIBLE NOTE PURCHASE AGREEMENT
(Filed With SEC on April 16, 2019)
-
Supply Agreement between the INVO Bioscience, Inc and Ferring International Center S.A
(Filed With SEC on April 16, 2019)
-
Form of Convertible Note Purchase Agreement 2018
(Filed With SEC on April 16, 2019)
-
Promissory Note August 2016
(Filed With SEC on April 16, 2019)
-
Form of Convertible Promissory Note 2018
(Filed With SEC on April 16, 2019)